Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.3%1-day move

₹1904.00

prior close

₹1900.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+0.6+0.4+0.2-1.3-0.9-3.4-3.2-3.2-5.3-6.1-3.3+2.8—

Up moveDown movePending

AI summary

Dilip S. Shanghvi, the founder and promoter of Sun Pharma, has submitted a declaration confirming that as of 31 March 2026, neither he nor the Promoter Group nor Persons Acting in Concert (PACs) have created any new encumbrance (pledge) on Sun Pharma shares beyond what was already disclosed during FY 2025-26. The filing includes PAN details of the promoter and 13 entities comprising the promoter group and PACs, including family members and related trusts and companies.

Likely market impact

This is a routine negative confirmation filing. No new pledges or encumbrances by the promoter group is a positive signal for minority shareholders as it indicates the promoter is not leveraging their stake amid current market conditions.